UBS衍生品策略师Shane Carroll指出，该行中国股票销售团队已识别出几个阻碍投资者的因素，包括直到3月全国人民代表大会（NPC）之前缺乏积极的市场催化剂、潜在的特朗普政府相关风险，以及人民币的快速贬值。

UBS downgraded Goldman Sachs (NYSE:GS) to Neutral from Buy as the Wall Street firm's business model relies heavily on Global ...

UBS analyst Erika Najarian has singled out Bank of America Corp.’s stock as an overlooked bargain that could rise about 20% ...

As of now, UBS analysts expect Partners Group's performance fees to contribute between 20% and 30% of total revenues in 2024, ...

AI stocks and the "Magnificent Seven" were clear winners in 2024. But after a solid year of growth and high valuations, will that momentum continue in 2025? Perhaps, says UBS. In a note, UBS head of U ...

Financial analysts from HSBC and UBS upgrade Bank of America to Buy, citing favorable earnings outlook and stock valuation in ...

Adobe could lose ground as rivals like OpenAI establish themselves in the market for creative artificial intelligence, UBS ...

Investing.com -- Shares of Boliden (ST: BOL) rose over 3% on Tuesday following an upgrade to a 'neutral' rating by analysts ...

UBS claims that although the larger market had a considerably lesser gain of 5.0%, the Big 6 saw profits rise of 38.9% in ...

Millions of Americans have watched their net worth spike since the pandemic, powered by meteoric gains in the stock market.

After a forgettable year, Morgan Stanley, UBS, Goldman Sachs and others make their predictions for Chinese equities in 2025.